FDA slams EpiPen maker for doing nothing while hundreds failed, people died | Ars Technica UK


The manufacturer of EpiPen devices failed to address known malfunctions in its epinephrine auto-injectors even as hundreds of customer complaints rolled in and failures were linked to deaths, according to the Food and Drug Administration. The damning allegations came to light today when the FDA posted a warning letter it sent September 5 to the manufacturer, Meridian Medical Technologies, Inc. The company (which is owned by Pfizer) produces EpiPens for Mylan, which owns the devices and is notorious for dramatically raising prices by more than 400 percent in recent years.The auto-injectors are designed to be used during life-threatening allergic reactions to provide a quick shot of epinephrine. If they fail to fire, people experiencing a reaction can die or suffer serious illnesses. According to the FDA, that’s exactly what happened for hundreds of customers.

Source: FDA slams EpiPen maker for doing nothing while hundreds failed, people died | Ars Technica UK

Mylan chairman: Drug pricing critics ought to go copulate with themselves | Ars Technica UK


Mr. Coury replied that he was untroubled. He raised both his middle fingers and explained, using colorful language, that anyone criticizing Mylan, including its employees, ought to go copulate with themselves. Critics in Congress and on Wall Street, he said, should do the same. And regulators at the Food and Drug Administration? They, too, deserved a round of anatomically challenging self-fulfillment.

Source: Mylan chairman: Drug pricing critics ought to go copulate with themselves | Ars Technica UK

For ripping off Medicaid, EpiPen maker Mylan pays Feds $465 million | Ars Technica


In settlement, Mylan doesn’t admit guilt for misclassifying life-saving device.

Source: For ripping off Medicaid, EpiPen maker Mylan pays Feds $465 million | Ars Technica

EpiPen Uproar Highlights Company’s Family Ties to Congress


The CEO of a former Fortune 500 company, who is also the daughter of a U.S. senator, is under fire for jacking up the rates of a life-saving anti-allergy treatment.

Source: EpiPen Uproar Highlights Company’s Family Ties to Congress